Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study

Diabetes, Obesity & Metabolism
D R MatthewsB Zinman

Abstract

To show that vildagliptin added to metformin is non-inferior to glimepiride in reducing HbA1c levels from baseline over 2 years. A randomized, double-blind, active-comparator study of patients with type 2 diabetes mellitus inadequately controlled (HbA1c 6.5-8.5%) by metformin monotherapy. Patients received vildagliptin (50 mg twice daily) or glimepiride (up to 6 mg/day) added to metformin. In all, 3118 patients were randomized (vildagliptin, n = 1562; glimepiride, n = 1556). From similar baseline values (7.3%), after 2 years adjusted mean (s.e.) change in HbA1c was comparable between vildagliptin and glimepiride treatment: -0.1% (0.0%) and -0.1% (0.0%), respectively. The primary objective of non-inferiority was met. A similar proportion of patients reached HbA1c <7% (36.9 and 38.3%, respectively), but with vildagliptin more patients reached this target without hypoglycaemia (36.0% vs. 28.8%; p = 0.004). The initial response (IR) was sustained for a mean (s.d.) of 309 (244) days with vildagliptin versus 270 (223) days for glimepiride (p < 0.001) (IR = nadir HbA1c where change from baseline > or =0.5% or HbA1c < or =6.5% within the first six months of treatment. After IR was detected, sustained response = time between nadir and a...Continue Reading

References

Jun 13, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·T M Wallace, D R Matthews
Dec 9, 2004·Current Opinion in Clinical Nutrition and Metabolic Care·Marie Thearle, Anne Marie B Brillantes
Jan 18, 2006·Diabetes & Metabolism·V Lassmann-Vague
Dec 6, 2006·The New England Journal of Medicine·Steven E KahnUNKNOWN ADOPT Study Group
Dec 6, 2006·The New England Journal of Medicine·David M Nathan
May 19, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·A SchweizerS Dejager
Nov 29, 2007·The Journal of Clinical Endocrinology and Metabolism·Koichiro AzumaDavid E Kelley
Jan 25, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·S A AmielK Jameson
Mar 18, 2008·Diabetic Medicine : a Journal of the British Diabetic Association·C PanJ E Foley
Apr 11, 2008·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·V FonsecaS Dejager
Aug 30, 2008·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·B GökeS Dejager
Oct 30, 2008·The Journal of Clinical Endocrinology and Metabolism·David A D'AlessioRichard E Pratley
Nov 27, 2008·Diabetes·Philip E Cryer
Dec 6, 2008·Diabetes Research and Clinical Practice·Simon R Heller
Dec 18, 2008·The Journal of Clinical Endocrinology and Metabolism·Michael BoschmannJens Jordan
Jan 3, 2009·Diabetes Research and Clinical Practice·Masatoshi KikuchiHideo Tachibana
Jan 29, 2009·The Journal of Clinical Endocrinology and Metabolism·Bo AhrénJames E Foley
Feb 18, 2009·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·M GoodmanJ Penman
Jun 23, 2009·Expert Opinion on Drug Safety·Joanna Mitri, Osama Hamdy

❮ Previous
Next ❯

Citations

Dec 1, 2011·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Sylvie Dejager, Anja Schweizer
Jun 28, 2012·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Anja SchweizerJames E Foley
Sep 3, 2013·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Serge HalimiSylvie Dejager
Feb 14, 2012·Diabetes Technology & Therapeutics·Giuseppe Derosa, Pamela Maffioli
Aug 17, 2011·Diabetes, Obesity & Metabolism·B Ahrén
Jun 5, 2012·Vascular Health and Risk Management·Sylvie DejagerJames E Foley
Feb 22, 2012·Clinical Pharmacokinetics·Yan-Ling He
Nov 6, 2012·World Journal of Diabetes·Matthias BlüherMarkus Dworak
Mar 8, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Masato OdawaraManabu Suzuki
Apr 15, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Dominique SimonSylvie Dejager
Mar 26, 2014·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Paul CraddyK Ian Johnson
May 17, 2011·Acta Diabetologica·Gian Paolo FadiniAngelo Avogaro
Mar 29, 2011·Hospital Practice·Isabelle Bourdel-MarchassonSylvie Dejager
Mar 9, 2012·Expert Opinion on Pharmacotherapy·Elisa GuarinoFrancesco Dotta
Dec 14, 2011·Expert Opinion on Pharmacotherapy·André J Scheen
Feb 20, 2014·Expert Opinion on Drug Metabolism & Toxicology·Stephanie A SteinStephen N Davis
Oct 30, 2014·Expert Opinion on Drug Safety·Anthony H Barnett
Jun 14, 2012·Expert Opinion on Drug Safety·Berit InksterBrian M Frier
May 7, 2013·La Presse médicale·Serge Halimi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.